Reuters logo
BRIEF-Venture Life Group says FDA approval to manufacture OTC drug products for US market
October 2, 2017 / 6:25 AM / in 15 days

BRIEF-Venture Life Group says FDA approval to manufacture OTC drug products for US market

Oct 2 (Reuters) - VENTURE LIFE GROUP PLC:

* FDA APPROVAL FOR THE US MARKET

* ‍FDA APPROVAL TO MANUFACTURE OTC DRUG PRODUCTS FOR US MARKET​

* ‍LONG-TERM DISTRIBUTION AGREEMENT FOR ULTRADEX IN FRANCE​

* ‍DEVELOPMENT AND MANUFACTURING FACILITY HAS GAINED US FDA APPROVAL FOR MANUFACTURE OFOVER COUNTER (“OTC”) DRUG PRODUCTS FOR US MARKET​

* ‍SEPARATELY, IT HAS SIGNED A LONG-TERM DISTRIBUTION AGREEMENT FOR ULTRADEX IN FRANCE​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below